Background: Varicella infections follow a benign course in around 90% of cases, with more severe forms occurring in adults. To identify potential pockets of susceptibility and to improve targeted immunization strategies, this study aims to critically assess immunological status by evaluating varicella seroprevalence among adults (18-99 years) in the province of Florence (Italy), nearly a decade after Tuscany introduced the vaccination program. Methods: A convenience sample of 430 subjects aged 18 to 94 years (mean age 51.8 +/- 18.8 years), stratified by age and sex (53.7% of subjects were female; N = 231), was collected between 2018 and 2019. Sero-analytical analyses were conducted utilizing EUROIMMUN Anti-VZV ELISA (IgG) kits. Results: Most of them were of Italian nationality (87.4%; N = 376). Among the 430 tested samples, 385 (89.5%) were positive and 39 (9.1%) were negative. The remaining six sera (1.4%), confirmed as equivocal, were excluded from further analysis. No significant differences were found based on sex (p-value = 0.706) or nationality (p-value = 0.112). The application of trend tests (Mantel-Haenszel; Kendall Tau-b) showed a significant trend (p < 0.024 and p < 0.032, respectively), with an increasing probability of finding a positive anti-varicella serological status passing from a lower age group (84.2%) to a higher one (93.0%). By considering the female population aged 18-49 years, the seroprevalence of anti-varicella antibodies was found to be 88.4%, with a susceptibility of 11.6%, highlighting the risk of acquiring infection during pregnancy. Conclusions: The introduction of varicella vaccination has had a significant impact on public health in Tuscany and in Italy more generally. However, further efforts should be made to reduce the number of individuals still susceptible in adulthood, with particular attention given to women of childbearing age and the promotion of vaccination through mass and social media and institutional websites.

Seroprevalence Assessment of Anti-Varicella Antibodies among Adults in the Province of Florence (Italy) / Bechini, Angela; Del Riccio, Marco; Salvati, Cristina; Bonito, Benedetta; Zanella, Beatrice; Biamonte, Massimiliano Alberto; Bruschi, Mario; Iamarino, Johanna Alexandra; Fattorini, Letizia; Baggiani, Lorenzo; Della Fonte, Monica; Mereu, Giovanna; Bonanni, Paolo; Group, Working; Boccalini, Sara. - In: VACCINES. - ISSN 2076-393X. - ELETTRONICO. - 12:(2024), pp. 1056.0-1056.0. [10.3390/vaccines12091056]

Seroprevalence Assessment of Anti-Varicella Antibodies among Adults in the Province of Florence (Italy)

Bechini, Angela
;
Del Riccio, Marco;Salvati, Cristina;Bonito, Benedetta;Zanella, Beatrice;Biamonte, Massimiliano Alberto;Bruschi, Mario;Iamarino, Johanna Alexandra;Fattorini, Letizia;Bonanni, Paolo;Boccalini, Sara
2024

Abstract

Background: Varicella infections follow a benign course in around 90% of cases, with more severe forms occurring in adults. To identify potential pockets of susceptibility and to improve targeted immunization strategies, this study aims to critically assess immunological status by evaluating varicella seroprevalence among adults (18-99 years) in the province of Florence (Italy), nearly a decade after Tuscany introduced the vaccination program. Methods: A convenience sample of 430 subjects aged 18 to 94 years (mean age 51.8 +/- 18.8 years), stratified by age and sex (53.7% of subjects were female; N = 231), was collected between 2018 and 2019. Sero-analytical analyses were conducted utilizing EUROIMMUN Anti-VZV ELISA (IgG) kits. Results: Most of them were of Italian nationality (87.4%; N = 376). Among the 430 tested samples, 385 (89.5%) were positive and 39 (9.1%) were negative. The remaining six sera (1.4%), confirmed as equivocal, were excluded from further analysis. No significant differences were found based on sex (p-value = 0.706) or nationality (p-value = 0.112). The application of trend tests (Mantel-Haenszel; Kendall Tau-b) showed a significant trend (p < 0.024 and p < 0.032, respectively), with an increasing probability of finding a positive anti-varicella serological status passing from a lower age group (84.2%) to a higher one (93.0%). By considering the female population aged 18-49 years, the seroprevalence of anti-varicella antibodies was found to be 88.4%, with a susceptibility of 11.6%, highlighting the risk of acquiring infection during pregnancy. Conclusions: The introduction of varicella vaccination has had a significant impact on public health in Tuscany and in Italy more generally. However, further efforts should be made to reduce the number of individuals still susceptible in adulthood, with particular attention given to women of childbearing age and the promotion of vaccination through mass and social media and institutional websites.
2024
12
0
0
Goal 3: Good health and well-being
Bechini, Angela; Del Riccio, Marco; Salvati, Cristina; Bonito, Benedetta; Zanella, Beatrice; Biamonte, Massimiliano Alberto; Bruschi, Mario; Iamarino,...espandi
File in questo prodotto:
File Dimensione Formato  
vaccines-12-01056.pdf

accesso aperto

Descrizione: Varicella Seroprevalence Florence
Tipologia: Pdf editoriale (Version of record)
Licenza: Creative commons
Dimensione 598.63 kB
Formato Adobe PDF
598.63 kB Adobe PDF

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificatore per citare o creare un link a questa risorsa: https://hdl.handle.net/2158/1401704
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
social impact